Trade Mark Journal No.2026/025 19 June 2026
UK00004367167 31 March 2026 (5,42,44)
ALTX
- Class 5
- Pharmaceutical preparations and substances; immunotherapy preparations; pharmaceutical and biological preparations and substances for immunotherapy; therapeutic vaccines; genetic medicines; diagnostic reagents for medical purposes; synthetic peptides, proteins and cells for pharmaceutical purposes; peptides, proteins and cells for medical, diagnostic or therapeutic purposes; in vitro diagnostic reagents, in vivo diagnostic reagents, immunological reagents for medical use; biological reagents for medical/clinical diagnosis; diagnostic kits comprising reagents and medical diagnostic tests; biological reagents for medical research; biological reagents for medical use; biological preparations for medical use; immuno-therapeutic agents; antigen binding molecules, antibodies, antibody fragments; pharmaceutical preparations and substances for the treatment of cancer; biotechnological preparations for the treatment of cancer; immunotherapy preparations for the treatment of cancer; genetic medicines for the treatment of cancer; immunotherapy products in oncology; preparation of therapeutic vaccines in oncology for human use; preparation of immunotherapy products in oncology for human use.
- Class 42
- Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; scientific research in the field of chemistry, biochemistry and biology; services of a biological, biochemical or chemical laboratory; performing of biological, biochemical or chemical analysis; cancer diagnostics for scientific purposes; biological and biochemical examination services; tests in laboratories; development of testing methods; research, development, technical design, testing, design and development of software in the field of biology; consultancy and analysis services in the field of immuno-therapeutics and in particular immune-oncology; Pharmaceutical product research and development; Biotechnology research and development; vaccine and immunotherapy research and development; research and development services in relation to pharmaceutical preparations and substances; research and development services in relation to pharmaceutical and biological preparations and substances for immunotherapy; research and development services in relation to gene therapy, cell therapy and genetic medicines; pharmaceutical and biological research and development services in connection with the treatment of cancer; advice, information and consultancy in connection with all of the aforesaid services.
- Class 44
- Provision of medical information; Provision of medical information via a website; medical counselling and medical information relating to pharmaceuticals, immunotherapy, immune-therapeutic treatments, therapeutic vaccines and genetic medicines; services of a medical laboratory, providing medical supply for therapy; medical diagnostics; medical monitoring, testing, inspection and analysis services; medical and pharmaceutical consultancy.
ALTX Therapeutics Limited
Representative: Downing IP Limited